Merck Makes Deal to Develop Schizophrenia Drug
15688
Merck agreed to pay a Swiss company, Addex Pharmaceuticals, as much as $702 million to help develop a new schizophrenia drug.
155751
NEW YORK/WHITEHOUSE STATION, New Jersey  - Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and it aims to have another four products in late-stage trials by mid-year, the company said on Tuesday.
681845
The pharmaceutical giant signs another collaborative research agreement with the small-cap company.
534842
The deal will settle claims that Merck overcharged Medicaid programs, and resolve charges over marketing.
733936
The first new class of drugs in more than a decade for treating schizophrenia worked at least as well in a clinical trial as standard medications, but with fewer side-effects, a new study showed.
700315
German drugmaker Merck KGaA   unveiled a surprise 16.6-billion-Swiss franc ($13.3  billion) deal to buy Swiss biotech firm Serono on Thursday,  creating a new force in European pharmaceuticals.
354080
The medicine is the first product of an innovative collaboration between a drug company and a medical charity.
522767
Arena Pharmaceuticals, Inc.   said on Monday that Merck & Co. Inc.  has  pulled out of a partnership to develop an experimental drug for  atherosclerosis after results from a mid-stage clinical trail.
531882
FRANKFURT/ZURICH  - Germany drugmaker Merck KGaA   MRCG.DE unveiled a surprise 16.6-billion-Swiss franc ($13.3   billion) deal on Thursday to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
374648
A schizophrenia drug from Johnson & Johnson won U.S. approval as the first medicine to treat symptoms of autism in children and adolescents, the Food and Drug Administration said on Friday.
287117
Drug company Eli Lilly  has encouraged primary care physicians to use Zyprexa, a powerful drug for schizophrenia and bipolar disorder, in patients who did not have either condition, the New York Times reported on its Web site on Monday, citing internal Lilly marketing materials.
96120
An experimental treatment for schizophrenia produced fewer worrisome side effects compared with drugs currently in use, its makers said on Wednesday.
400715
Microbia Inc., a promising Cambridge biotech company, said it has signed a multimillion-dollar deal with a New York drug company to jointly develop and market Microbia's first drug.
105464
The Food and Drug Administration approved the use of the drug Risperdal for treating schizophrenia and bipolar disorder in children and teenagers.
112414
Internal documents show that the company knew of serious side effects of Zyprexa, its best-selling medication for schizophrenia.
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
214430
With its stock plunging, drug giant Merck has adopted a plan that could give top executives big bonuses if the company is taken over.